Canola Oil Multi-center Intervention Trial II

NCT03054779 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2023-08-21

No results posted yet for this study

Summary

Building on the findings from the investigators previous study, COMIT I, the purpose of the COMIT II study is to supplement the DEXA measurement of body composition with a supplementary DEXA measurement of visceral adipose tissue and to specifically target the impact of oleic acid consumption on body composition as the primary objective. COMIT II also will include analysis of fatty acid ethanolamines (FAEs) and their precursors to elucidate the mechanisms by which canola oil may be modifying body composition, measurement of endothelial function, inflammatory, adiposity and insulin sensitivity biomarkers, and genetic analyses.

Conditions

Interventions

OTHER

Canola Oil

Regular canola oil will be iso-calorically incorporated into fruit smoothies made with milk and consumed twice daily.

OTHER

High oleic acid canola oil

High oleic acid canola oil will be iso-calorically incorporated into fruit smoothies made with milk and consumed twice daily.

OTHER

Western diet oil combination

A typical "Western diet" fat intake as a control treatment, comprised of 11% MUFA, 11% PUFA (9% omega-6 fatty acids and 2% omega-3 fatty acids), and 13% SFA, will be iso-calorically incorporated into fruit smoothies made with milk and consumed twice daily

Sponsors & Collaborators

  • Canola Council of Canada

    collaborator OTHER
  • University of Manitoba

    collaborator OTHER
  • Laval University

    collaborator OTHER
  • Unity Health Toronto

    collaborator OTHER
  • St. Boniface Hospital

    collaborator OTHER
  • Penn State University

    lead OTHER

Principal Investigators

  • Penny M Kris-Etherton, PhD · Penn State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03054779 on ClinicalTrials.gov